tradingkey.logo

Lisata Therapeutics Enters Into Definitive Agreement To Be Acquired By Kuva Labs, Inc.

ReutersMar 6, 2026 11:21 PM

- Lisata Therapeutics Inc LSTA.O:

  • LISATA THERAPEUTICS ENTERS INTO DEFINITIVE AGREEMENT TO BE ACQUIRED BY KUVA LABS, INC.

  • LISATA THERAPEUTICS INC - KUVA TO BUY LISATA FOR $5.00 PER SHARE IN CASH PLUS ONE CVR PER SHARE

  • LISATA THERAPEUTICS INC - CVR ENTITLES ADDITIONAL $1.00 PER SHARE IF NDA FOR CERTEPETIDE IS FILED OR ACCEPTED

  • LISATA THERAPEUTICS INC - BOARD UNANIMOUSLY APPROVES DEAL AND RECOMMENDS STOCKHOLDERS TENDER SHARES

  • LISATA THERAPEUTICS INC - TO BE DELISTED FROM NASDAQ AND DEREGISTER AS REPORTING COMPANY AFTER DEAL CLOSE

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI